Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-02 @ 4:26 PM
Study NCT ID:
NCT05557851
Status:
UNKNOWN
Last Update Posted:
2022-12-09
First Post:
2022-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
Sponsor:
Minneamrita Therapeutics LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Minnelide_ACP_101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None